1
Mulder, Rene, Lisman, Ton, Meijers, Joost C. M., Huntington, James A., Mulder, Andre B., Meijer, Karina
Veröffentlicht in: Mulder , R , Lisman , T , Meijers , J C M , Huntington , J A , Mulder , A B & Meijer , K 2020 , ' Linkage analysis combined with whole-exome sequencing identifies a novel prothrombin (F2) gene mutation in a Dutch Caucasian family with unexplained thrombosis ' , Haematologica , vol. 105 , no. 7 , pp. E370-E372 . https://doi.org/10.3324/haematol.2019.232504;
2020
Veröffentlicht in: Mulder , R , Lisman , T , Meijers , J C M , Huntington , J A , Mulder , A B & Meijer , K 2020 , ' Linkage analysis combined with whole-exome sequencing identifies a novel prothrombin (F2) gene mutation in a Dutch Caucasian family with unexplained thrombosis ' , Haematologica , vol. 105 , no. 7 , pp. E370-E372 . https://doi.org/10.3324/haematol.2019.232504;
2020
2
3
4
Seelig, Jaap, Hemels, Martin E. W., Xhaet, Olivier, Bongaerts, Maarten C. M., de Wolf, Axel, Groenemeijer, Bjorn E., Heyse, Alex, Hoogslag, Pieter, Voet, Joeri, Herrman, Jean-Paul R., Vervoort, Geert, Hermans, Walter, Wollaert, Bart, Boersma, Lucas V. A., Hermans, Kurt, Lucassen, Andreas, Verstraete, Stefan, Adriaansen, Henk J., Mairesse, Georges H., Terpstra, Willem F., Faes, Dirk, Pieterse, Mathijs, Virdone, Saverio, Verheugt, Freek W. A., Cools, Frank, ten Cate, Hugo
Veröffentlicht in: Seelig , J , Hemels , M E W , Xhaet , O , Bongaerts , M C M , de Wolf , A , Groenemeijer , B E , Heyse , A , Hoogslag , P , Voet , J , Herrman , J-P R , Vervoort , G , Hermans , W , Wollaert , B , Boersma , L V A , Hermans , K , Lucassen , A , Verstraete , S , Adriaansen , H J , Mairesse , G H , Terpstra , W F , Faes , D , Pieterse , M , Virdone , S , Verheugt , F W A , Cools , F , ten Cate , H & GARFIELD-AF Investigators 2020 , ' Impact of different anticoagulation management strategies on outcomes in atrial fibrillation : Dutch and Belgian results from the GARFIELD-AF registry ' , Journal of Thrombosis and Haemostasis , vol. 18 , no. 12 , pp. 3280-3288 . https://doi.org/10.1111/jth.15081;
2020
Veröffentlicht in: Seelig , J , Hemels , M E W , Xhaet , O , Bongaerts , M C M , de Wolf , A , Groenemeijer , B E , Heyse , A , Hoogslag , P , Voet , J , Herrman , J-P R , Vervoort , G , Hermans , W , Wollaert , B , Boersma , L V A , Hermans , K , Lucassen , A , Verstraete , S , Adriaansen , H J , Mairesse , G H , Terpstra , W F , Faes , D , Pieterse , M , Virdone , S , Verheugt , F W A , Cools , F , ten Cate , H & GARFIELD-AF Investigators 2020 , ' Impact of different anticoagulation management strategies on outcomes in atrial fibrillation : Dutch and Belgian results from the GARFIELD-AF registry ' , Journal of Thrombosis and Haemostasis , vol. 18 , no. 12 , pp. 3280-3288 . https://doi.org/10.1111/jth.15081;
2020
5
6
Jihee Han, Ruifang Li‐Gao, Renée deMutsert, Frits R. Rosendaal, Astrid vanHylckama Vlieg
Veröffentlicht in: eJHaem, Vol 5, Iss 1, Pp 47-54 (2024);
2024
Veröffentlicht in: eJHaem, Vol 5, Iss 1, Pp 47-54 (2024);
2024
7
8
9
de Jong, Lisa A, Dvortsin, Evgeni, Janssen, Kristel J., Postma, Maarten J.
Veröffentlicht in: de Jong , L A , Dvortsin , E , Janssen , K J & Postma , M J 2017 , ' Cost-effectiveness Analysis for Apixaban in the Acute Treatment and Prevention of Venous Thromboembolism in the Netherlands ' , Clinical Therapeutics , vol. 39 , no. 2 , pp. 288-302 . https://doi.org/10.1016/j.clinthera.2016.12.012;
2017
Veröffentlicht in: de Jong , L A , Dvortsin , E , Janssen , K J & Postma , M J 2017 , ' Cost-effectiveness Analysis for Apixaban in the Acute Treatment and Prevention of Venous Thromboembolism in the Netherlands ' , Clinical Therapeutics , vol. 39 , no. 2 , pp. 288-302 . https://doi.org/10.1016/j.clinthera.2016.12.012;
2017
10
Heisen, Marieke, Treur, Maarten J, Heemstra, Harald E, Giesen, Eric B W, Postma, Maarten J
Veröffentlicht in: Heisen , M , Treur , M J , Heemstra , H E , Giesen , E B W & Postma , M J 2017 , ' Cost-effectiveness analysis of rivaroxaban for treatment and secondary prevention of venous thromboembolism in the Netherlands ' , Journal of Medical Economics , vol. 20 , no. 8 , 0046-RT.R1/1331912 , pp. 813-824 . https://doi.org/10.1080/13696998.2017.1331912;
2017
Veröffentlicht in: Heisen , M , Treur , M J , Heemstra , H E , Giesen , E B W & Postma , M J 2017 , ' Cost-effectiveness analysis of rivaroxaban for treatment and secondary prevention of venous thromboembolism in the Netherlands ' , Journal of Medical Economics , vol. 20 , no. 8 , 0046-RT.R1/1331912 , pp. 813-824 . https://doi.org/10.1080/13696998.2017.1331912;
2017